scholarly journals Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study

2009 ◽  
pp. 723 ◽  
Author(s):  
Vivencio Barrios
Keyword(s):  
Blood Pressure ◽  
Olmesartan Medoxomil ◽  
Goal Achievement ◽  
Additional Analysis ◽  
Blood Pressure Goal

155 Door to Blood Pressure Goal Achievement in Community Management of Hyperacute Intracerebral Hemorrhage

2012 ◽  
Vol 60 (4) ◽  
pp. S56 ◽  
Author(s):  
N. Sanossian ◽  
A. Flinders ◽  
E. Olivas ◽  
S. Starkman ◽  
D. Liebeskind ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Intracerebral Hemorrhage ◽  
Goal Achievement ◽  
Community Management ◽  
Blood Pressure Goal

Does socioeconomic status affect blood pressure goal achievement?

2008 ◽  
Vol 10 (5) ◽  
pp. 390-397 ◽  
Author(s):  
Deborah Minor ◽  
Marion Wofford ◽  
Sharon B. Wyatt
Keyword(s):  
Blood Pressure ◽  
Socioeconomic Status ◽  
Goal Achievement ◽  
Blood Pressure Goal

scholarly journals Hypertension Control and Guideline-Recommended Target Blood Pressure Goal Achievement at an Early Stage of Hypertension in the UAE

2021 ◽  
Vol 11 (1) ◽  
pp. 47
Author(s):  
Akshaya Srikanth Bhagavathula ◽  
Syed Mahboob Shah ◽  
Abubaker Suliman ◽  
Abderrahim Oulhaj ◽  
Elhadi Husein Aburawi
Keyword(s):  
Blood Pressure ◽  
United Arab Emirates ◽  
Treatment Initiation ◽  
Early Stage ◽  
Goal Achievement ◽  
Blood Pressure Goal ◽  
Hypertension Control ◽  
Lifestyle Modifications ◽  
Factors Associated ◽  
The Mean

(1) Background: The present study aimed to assess the changes in blood pressure (BP) within the first 6 months of treatment initiation in a newly treated hypertensive cohort and to identify the factors that are associated with achieving the target BP recommended by the American (ACC/AHA, 2017), European (ESC/ESH, 2018), United Kingdom (NICE, 2019), and International Society of Hypertension (ISH, 2020) guidelines. (2) Methods: We analyzed 5308 incident hypertensive outpatients across Abu Dhabi, United Arab Emirates (UAE), in 2017; each patient was followed up for 6 months. Hypertension was defined as a BP of 130/80 mmHg according to the ACC/AHA guidelines and 140/90 mmHg according to the ESC/ESH, NICE, and ISH guidelines. Multiple logistic regression was used to identify factors associated with achieving the guideline-recommended BP targets. (3) Results: At baseline, the mean BP was 133.9 ± 72.9 mmHg and 132.7 ± 72.5 mmHg at 6 months. The guideline-recommended BP targets were 39.5%, 43%, 65.6%, and 40.8%, according to the ACC/AHA, ESC/ESH, NICE, and ISH guidelines, respectively. A BMI of <25 kg/m2 was associated with better BP control according to the ACC/AHA (odds ratio (OR) = 1.26; 95% confidence interval (CI) = 1.07–1.49), ESC/ESH (OR = 1.27; 95% CI = 1.08–1.50), and ISH guidelines (OR = 1.22; 95% CI = 1.03–1.44). Hypertension treated in secondary care settings was more likely to achieve the BP targets recommended by the ACC/AHA (1.31 times), ESC/ESH (1.32 times), NICE (1.41 times), and ISH (1.34 times) guidelines. (4) Conclusions: BP goal achievement was suboptimal. BP control efforts should prioritize improving cardiometabolic goals and lifestyle modifications.

scholarly journals Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Elisabeth Pedersen ◽  
Beate Hennie Garcia ◽  
Kjell H. Halvorsen ◽  
Anne Elise Eggen ◽  
Henrik Schirmer ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Clinical Practice ◽  
Ldl Cholesterol ◽  
Antihypertensive Drugs ◽  
Goal Achievement ◽  
Treatment Goal ◽  
Blood Pressure Goal ◽  
Treatment Goals

Abstract Background Adherence to clinical practice guidelines for coronary heart disease (CHD) reduces morbidity, mortality and treatment costs. We aimed to describe and compare adherence to prescription guidelines for persons with CHD, and explore its association with treatment goal achievement. Method We included all participants reporting myocardial infarction, angina, percutaneous coronary intervention and/or coronary artery bypass surgery in the seventh wave of the Tromsø Study (2015–2016, n = 1483). Medication use and treatment goal measures (blood pressure, low-density lipoprotein (LDL)-cholesterol and HbA1c) were compared to clinical practice guidelines on secondary CHD prevention. Propensity score matched logistic regression was used to assess the association between the use of antihypertensive drugs and achievement of treatment goal for blood pressure, and the use of lipid-lowering drugs (LLDs) and achievement of treatment goal for LDL-cholesterol. Results The prevalence of pharmacological CHD treatment was 76% for LLDs, 72% for antihypertensive drugs and 66% for acetylsalicylic acid. The blood pressure goal (< 140/90 mmHg, < 140/80 mmHg if diabetic) was achieved by 58% and the LDL-cholesterol goal (< 1.8 mmol/l or < 70 mg/dL) by 9%. There was a strong association between using LLDs and achieving the treatment goal for LDL-cholesterol (OR 14.0, 95% CI 3.6–54.7), but not between using antihypertensive drugs and blood pressure goal achievement (OR 1.4, 95% CI 0.7–2.7). Conclusion Treatment goal achievement of LDL-cholesterol and blood pressure was low, despite the relatively high use of LLDs and antihypertensive drugs. Further research is needed to find the proper actions to increase achievement of the treatment goals.

Sign in / Sign up

Export Citation Format

Share Document